Language and Motor Skills of Preterm Infants in Pre-school Age: Diagnosis and Early Intervention
NCT ID: NCT01426659
Last Updated: 2015-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
139 participants
INTERVENTIONAL
2011-09-30
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Early intervention on the basis of precise language before closing the window developmental (\<5 years) is expected to improve as a result of language and cognitive development of preterm infants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on the Phenotype of Language in Preterm Born Children at 5 Years of Age
NCT02988570
Language and Motricity in Preterm School Age Children
NCT02811029
Longitudinal Assessment of Early Premature Infant Skills for Audiovisual Speech Perception
NCT07245693
Very Preterm Children With Language Delay and Parent Intervention
NCT02042235
Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder
NCT04253600
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To evaluate the interest of accurate and early stimulation implied short ("say and do") on areas of weakness in the language 3ans1 / 2 of the former preterm infants without CP spotted by BILO.
Method: This is a prevention trial national, multicenter, prospective randomized two arms. In this study, 296 patients with premature frailty of oral language without CP, with or without minor neurological disorder, and without proven pathology of oral language will be included in 5 hospitals and will be randomized to receive or not a specific stimulation (say and do " ). The assessment of oral language by a Computerized Assessment BILO1 (Khomsa 2008) ½ to 3 years will be offered to all parents of children with CP followed without neurosensory disorder or current fact. After obtaining consent, and results BILO, directed by a therapist trained in order to define the criteria for frailty, randomization will be done centrally. Early stimulation precise and short (20 therapy sessions per week) on these areas of weaknesses of language drive will be compared to the absence of specific stimulation. Evaluation at 6 months results will be blinded.
Inclusion is scheduled 24 months for the inclusion of patients with results defining areas of weakness in BILO1dans one of the components of language: an item \<10th percentile and / or two items \<25th percentile). .
Excluding children with pathological scores BILO1 (\<3rd percentile for at least one criterion) will not be included Primary endpoint: difference from baseline and after six months of phonology BILO score (score from 0 to 16 listed) Number of subjects and statistical power: 170 children a year born very preterm live out the CHU of Rouen. One hundred are followed and accept the studies conducted in the service as in other centers who collaborated in the study EPIPAGE (Lancet 2008). According to our preliminary work half the present language problems at 3 years. Thus, 50 children per year would be candidates for the study but 10% are pathological oral language and therefore excluded from the study. 296 children were included in five centers and according to their follow-up rate according to these proportions. Three centers have follow-up of very preterm and 80/an a regional 30/an. According to preliminary data, and assuming a moderate correlation of 0.5 between BILO scores at baseline and after six months, the standard deviation of the primary endpoint was 4.7 units of phonology BILO score. Thus, to test the risk of first kind of b = 5% in bilateral formulation, the total of 296 children included and evaluated (or 148 children per group) to detect with a statistical power of 90%, size effect of 0.379, a difference of 1.8 units average score BILO groupes. Ainsi between the two, the number chosen to detect with a high power low difference between the two groups for the primary .
Statistical analysis: The means of the primary endpoint will be compared between groups by one-tailed t test at the usual 5%. This test will be completed by comparing adjusted based on multiple linear regression model taking into account possible prognostic factors (duration of gestation, bronchopulmonary dysplasia, neurological disorders minors, socio-economic status ...), the center and the initial value ( to 3 years) score phonology. The difference in means between two groups and its confidence interval 95% will be estimated.
Outlook: Creating a cohort followed to analyze the impact of early stimulation specific to the age of 6 and assess our level of prevention of disorders of oral and written language.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Protocol "say and do"
reeducation implicit 5 minutes every day at home and 30 minutes of speech therapy every week
parental stimulation according to protocol
verbal stimulation every day image of the Protocol "Dire et Faire"
no stimulation "say and do"
parental stimulation according to protocol
verbal stimulation every day image of the Protocol "Dire et Faire"
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
parental stimulation according to protocol
verbal stimulation every day image of the Protocol "Dire et Faire"
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* criteria of fragility BILO
Exclusion Criteria
* deafness,
* abnormal karyotype results in normal or pathological BILO
34 Months
38 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Regional Development Fund
OTHER
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
A Charollais
Role: PRINCIPAL_INVESTIGATOR
UH Rouen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Rouen, Haute Normandie, France
University Hospital
Caen, , France
University Hospital
Grenoble, , France
University Hospital
Le Havre, , France
Centre Jacques Cartier
Saint-Brieuc, , France
University Hospital
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Charollais A, Stumpf MH, Beaugrand D, Lemarchand M, Radi S, Pasquet F, Khomsi A, Marret S. [Evaluation of language at 6 years in children born prematurely without cerebral palsy: prospective study of 55 children]. Arch Pediatr. 2010 Oct;17(10):1433-9. doi: 10.1016/j.arcped.2010.06.012. Epub 2010 Aug 16. French.
Charollais A, Laudenbach V, Stumpf MH, Delaporte B, Datin-Dorriere V, Debillon T, De Barace C, Flechelles O, Farmer M. Impact of an early educational protocol on the oral language of children born preterm exhibiting phonological fragility: a multicenter randomized clinical trial. Front Psychol. 2024 Dec 5;15:1393246. doi: 10.3389/fpsyg.2024.1393246. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010/089/HP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.